Brief: AFT Pharmaceuticals Says Half-Year Operating Revenue Up 18.4%

AFT Pharmaceuticals

23/11/2022 22:27

Nov 24 (Reuters) - AFT Pharmaceuticals Ltd  AFT.NZ :
    * HALF-YEAR OPERATING REVENUE UP 18.4% TO NZ$65.8 MILLION
    * HY NET PROFIT AFTER TAX DECREASED TO NZ$1.5 MILLION FROM
NZ$4.2
MILLION
    * AFT CONTINUES TO EXPECT TO DECLARE A DIVIDEND FOR YEAR TO
END OF
MARCH 2023
    * NEW GUIDANCE FOR FY23 OPERATING PROFIT OF NZ$18 MILLION TO
NZ$23
MILLION
    * TARGETING NEAR TERM ANNUAL REVENUE OF NZ$200 MILLION
    * EXPECT RESULT FOR FULL YEAR TO BE EVEN MORE SKEWED TO H2
THAN
NORMAL
    * INCREASING ITS INVESTMENT IN GROWTH IN NEAR FUTURE
    * EXPECT TO DECLARE A MAIDEN DIVIDEND FOR 2023 FINANCIAL
YEAR
    * EXPECT THE RESULT FOR FULL YEAR TO BE EVEN MORE SKEWED TO
THE 
SECOND HALF THAN NORMAL
    * SEEING STRONG GROWTH IN DEMAND FOR PRODUCTS

Further company coverage:  AFT.NZ 
 ((reuters.briefs@thomsonreuters.com;))